Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | 2019

Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks.

 
 
 
 
 
 
 
 
 
 
 
 

Abstract


BACKGROUND\nIndividuals with cystic fibrosis (CF) experience elevated inflammation in multiple organs, but whether this reflects an inherent feature of CF cells or is a consequence of a pro-inflammatory environment is not clear.\n\n\nMETHOD\nUsing CRISPR/Cas9-mediated mutagenesis of CFTR, 17 subclonal cell lines were generated from Caco-2 cells. Clonal lines with functional CFTR (CFTR+) were compared to those without (CFTR-) to directly address the role of CFTR in inflammatory gene regulation.\n\n\nRESULTS\nAll lines maintained CFTR mRNA production and formation of tight junctions. CFTR+ lines displayed short circuit currents in response to forskolin, while the CFTR- lines did not. Baseline expression of cytokines IL6 and CXCL8 (IL8) was not different between the lines regardless of CFTR genotype. All lines responded to TNFα and IL1β by increasing IL6 and CXCL8 mRNA levels, but the CFTR- lines produced more CXCL8 mRNA than the CFTR+ lines. Transcriptomes of 6 CFTR- and 6 CFTR+ lines, before and after stimulation by TNFα, were compared for differential expression as a function of CFTR genotype. While some genes appeared to be differentially expressed simply because of CFTR s absence, others required stimulation for differences to be apparent.\n\n\nCONCLUSION\nTogether, these data suggest cells respond to CFTR s absence by modulating transcriptional networks, some of which are only apparent when cells are exposed to different environmental contexts, such as inflammation. With regards to inflammation, these data suggest a model in which CFTR s absence leads to a poised, pro-inflammatory state of cells that is only revealed by stimulation.

Volume None
Pages None
DOI 10.1016/j.jcf.2019.05.003
Language English
Journal Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Full Text